Key result
Multi-view EchoPrime fine-tuning improves LVEF estimation error by ~1 point over baseline.
Why the study?
Echocardiographic LVEF estimation in cardio-oncology is highly operator dependent and often detects declines only after myocardial injury has progressed, motivating automated methods for standardized assessment and earlier LV dysfunction detection.
Does a multi-task deep learning framework combining cardiac cycle-based temporal standardization, EchoPrime foundation model fine-tuning, and attention-based multi-view fusion improve automated LVEF estimation and LV dysfunction classification from echocardiography in cardio-oncology patients?
Does a multi-task deep learning framework combining cardiac cycle-based temporal standardization, EchoPrime foundation model fine-tuning, and attention-based multi-view fusion improve automated LVEF estimation and LV dysfunction classification from echocardiography in cardio-oncology patients?
Answers are grounded in this paper and cite their sources.
End-to-end fine-tuning of the EchoPrime echocardiographic foundation model with cardiac cycle standardization and attention-based multi-view fusion enables accurate automated LVEF estimation and LV dysfunction detection in cardio-oncology.
In cardio-oncology, left ventricular ejection fraction (LVEF) is the standard biomarker for monitoring cardiac function during cancer therapy. However, its estimation from echocardiography is highly operator dependent, and clinically meaningful declines are often detected only after myocardial injury has progressed, motivating automated methods for standardized assessment and earlier detection of LV dysfunction. To address this need, we propose a multi-task framework integrating cardiac cycle-based temporal standardization, multi-view spatiotemporal feature extraction, and joint optimization for LVEF estimation and LV dysfunction classification. Apical four- and two-chamber echocardiographic sequences are temporally standardized by sampling a clip over an estimated cardiac cycle before being processed by the EchoPrime foundation model, which is fine-tuned end-to-end within the proposed architecture. View-specific features are fused through an attention-based aggregation module to generate a patient-level embedding, from which two task-specific prediction heads estimate continuous LVEF and binary LV dysfunction. To broaden the LVEF distribution encountered during training, samples from the MIMIC-IV-ECHO dataset are incorporated using a balanced sampling strategy. Evaluated on the EchoRisk-MICCAI Challenge, our method achieves an MAE of 4.003 for LVEF estimation (Task 1) and an AUC of 0.764 for LV dysfunction detection (Task 2) on the validation set, demonstrating the effectiveness of foundation model fine-tuning with attention-based multi-view fusion for automated cardiac function assessment in cardio-oncology.
No takes yet. Share an insight, caveat, or question.
Freitas et al. (2026) studied Cardio-oncology cardiac function surveillance and left ventricular dysfunction (n=422). Fine-tuned EchoPrime foundation model with cardiac cycle-based temporal standardization, attention-based multi-view fusion, and auxiliary MIMIC-IV-ECHO supervision vs. EchoRisk challenge baseline model and ablated EchoPrime variants was evaluated on Left ventricular ejection fraction (LVEF) estimation (Task 1, MAE) and left ventricular (LV) dysfunction classification (Task 2, AUC) on the EchoRisk validation set (MAE 4.003 for LVEF estimation; AUC 0.764 for LV dysfunction classification). Fine-tuning EchoPrime with multi-view attention fusion achieved an MAE of 4.003 for LVEF estimation and an AUC of 0.764 for LV dysfunction detection vs 5.020 and 0.755 for the baseline.
Synapse has enriched 10 related papers. Consider them for comparative context: